Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Colorectal cancer (CRC) is the third most common cancer worldwide, with high morbidity and mortality rates. The diagnosis and treatment of CRC have the most significant value for disease- free survival. Early diagnosis and early surgical resection are generally considered to be the most effective ways to reduce CRC mortality. In the past few years, many researchers have focused on the role of microRNAs in different tumors, making the functions of microRNAs gradually clear. The present study reviews the role of microRNAs in the diagnosis and treatment of colorectal cancer. Compared with the usual diagnosis methods and biomarker, circulating microRNAs can be promising new effective biomarkers for CRC diagnosis and treatment.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530320999200818134339
2021-01-01
2025-07-04
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530320999200818134339
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test